Alx Oncology Holdings Stock Volatility Indicators Average True Range

ALXO Stock  USD 1.10  0.03  2.80%   
Alx Oncology volatility indicators tool provides the execution environment for running the Average True Range indicator and other technical functions against Alx Oncology. Alx Oncology value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of volatility indicators indicators. As with most other technical indicators, the Average True Range indicator function is designed to identify and follow existing trends. Alx Oncology volatility indicators enable investors to predict price movements based on how different True Range indicators change over time. Please specify Time Period to run this model.

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty-one with a total number of output elements of fourty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Alx Oncology Holdings volatility. High ATR values indicate high volatility, and low values indicate low volatility.
JavaScript chart by amCharts 3.21.15Dec2025FebJan 20Jan 27FebFeb 10Feb 17Feb 241.11.21.31.41.51.61.71.8 500K1M1.5M2M2.5M3M3.5M4M4.5M5M5.5M6M 0.1300.1350.1400.1450.1500.1550.1600.1650.1700.1750.1800.1850.1900.1950.2000.205 43.1K43.2K43.3K43.4K43.5K43.6K43.7K43.8K43.9K44K44.1K44.2K44.3K44.4K44.5K44.6K44.7K44.8K44.9K Show all
JavaScript chart by amCharts 3.21.15Alx Oncology Holdings Volume Alx Oncology Holdings Closing Prices Dow Jones Industrial Closing Prices - Benchmark Alx Oncology Holdings Average True Range

Alx Oncology Technical Analysis Modules

Most technical analysis of Alx Oncology help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Alx from various momentum indicators to cycle indicators. When you analyze Alx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Alx Oncology Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Alx Oncology Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Alx Oncology Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Alx Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Alx Oncology's daily price indicators and compare them against related drivers, such as volatility indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Alx Oncology's intrinsic value. In addition to deriving basic predictive indicators for Alx Oncology, we also check how macroeconomic factors affect Alx Oncology price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2022 2023 2024 2025 (projected)
Current Ratio9.575.246.035.73
Net Debt To EBITDA2.230.03290.03780.0359
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Alx Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.061.108.22
Details
Intrinsic
Valuation
LowRealHigh
0.051.078.19
Details
Naive
Forecast
LowNextHigh
0.021.208.32
Details
7 Analysts
Consensus
LowTargetHigh
6.987.678.51
Details

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Alx Oncology Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alx Oncology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alx Oncology Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alx Oncology Holdings Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alx Oncology Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alx Oncology. If investors know Alx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alx Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.97)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.49)
Return On Equity
(0.99)
The market value of Alx Oncology Holdings is measured differently than its book value, which is the value of Alx that is recorded on the company's balance sheet. Investors also form their own opinion of Alx Oncology's value that differs from its market value or its book value, called intrinsic value, which is Alx Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alx Oncology's market value can be influenced by many factors that don't directly affect Alx Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alx Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alx Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alx Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Discover investing ideas

Utilize additional investing modules